Enara Bio
Sophie joined Enara Bio in February 2022 from King’s College London (KCL) and Guy’s and St Thomas’ NHS Foundation Trust (GSTFT) where she was a Clinical Reader in Immuno-oncology and Consultant Medical Oncologist, with over 17 years’ experience.
As a medical oncologist, Sophie has extensive clinical trial experience as a principal investigator in the GSTFT early phase trials team, with a particular focus on the design and delivery of first-in-human studies of T-cell therapies for solid tumors.
Sophie completed her medical training at the University of Oxford and Imperial College London and went on to complete a PhD in solid tumor CAR T-cell cancer immunotherapy at King’s College London.
This person is not in any teams
This person is not in any offices
Enara Bio
Enara Bio’s mission is to shine a light on unconventional targets and develop the next generation of cancer immunotherapies designed to treat a broad patient population. Enara Bio is exploring the hidden depths of cancer and T-cell biology to discover and characterize novel immunotherapy targets, such as MR1-presented ligands and Dark Antigens™, which arise from altered cellular processes in cancer cells.